NEUROCOGNITIVE CHANGES FOLLOWING ANTIDEPRESSANT OR ANTIPSYCHOTIC TREATMENT IN THE SCHIZOPHRENIA PRODROME

被引：0
|
作者：
Bowie, Christopher R. [1 ]
Smith, C. W. [2 ]
McLaughlin, D. [2 ]
Auther, A. [2 ]
Cornblatt, B. [2 ]
机构：
[1] Queens Univ, Kingston, ON, Canada
[2] Hillside Hosp, Glen Oaks, NY 11004 USA
来源：
SCHIZOPHRENIA BULLETIN | 2009年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
下载
收藏
页码：302 / 302
页数：1
相关论文
共 50 条
  • [31] Co-treatment of buspirone with atypical antipsychotic drugs (AAPDs) improved neurocognitive function in chronic schizophrenia
    Wang, Yu
    Yang, Xiao
    Song, Xiuli
    Zhao, Liansheng
    Wei, Jinxue
    Wang, Jixiang
    Tian, Hong
    Zheng, Congyu
    Wei, Min
    Wang, Qiang
    Guo, Wanjun
    Deng, Wei
    Li, Tao
    Ma, Xiaohong
    SCHIZOPHRENIA RESEARCH, 2019, 209 : 135 - 140
  • [32] Neurocognitive trajectories and their clinical implications in first-episode schizophrenia after one year of antipsychotic treatment
    Huang, Bing-jie
    Pu, Cheng-cheng
    Miao, Qi
    Ma, Ke
    Cheng, Zhang
    Shi, Chuan
    Yu, Xin
    SCHIZOPHRENIA RESEARCH, 2022, 241 : 292 - 297
  • [33] The relationship of cognition changes and other symptoms following antipsychotic treatment
    Marquez, E
    Keefe, RSE
    Purdon, SE
    Rock, SL
    Alaka, KJ
    Ahmed, S
    Mohs, RC
    BIOLOGICAL PSYCHIATRY, 2004, 55 : 175S - 175S
  • [34] CHANGES IN SPONTANEOUS BRAIN ACTIVITY PATTERNS IN ANTIPSYCHOTIC NAIVE SCHIZOPHRENIA PATIENTS BEFORE AND AFTER ANTIPSYCHOTIC TREATMENT
    Rostrup, Egill
    Nielsen, Mette O.
    Raghava, Jaychandra M.
    Glenthoj, Birte
    SCHIZOPHRENIA RESEARCH, 2012, 136 : S102 - S103
  • [35] Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial
    Keefe, Richard
    Bilder, Robert M.
    Davis, Sonia M.
    Harvey, Philip D.
    Palmer, Barton W.
    Gold, James M.
    Meltzer, Herbert Y.
    Green, Michael F.
    Capuano, George
    Stroup, T. S.
    McEvoy, Joseph P.
    Swartz, Marvin S.
    Rosenheck, Robert A.
    Perkins, Diana O.
    Davis, Clarence E.
    Hsiao, John K.
    Lieberman, Jeffrey A.
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S244 - S245
  • [36] Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial
    Keefe, Richard S. E.
    Bilder, Robert M.
    Davis, Sonia M.
    Harvey, Philip D.
    Palmer, Barton W.
    Gold, James M.
    Meltzer, Herbert Y.
    Green, Michael F.
    Capuano, George
    Stroup, T. Scott
    McEvoy, Joseph P.
    Swartz, Marvin S.
    Roscnheck, Robert A.
    Perkins, Diana O.
    Davis, Clarence E.
    Hsiao, John K.
    Lieberman, Jcffrey A.
    ARCHIVES OF GENERAL PSYCHIATRY, 2007, 64 (06) : 633 - 647
  • [37] CENTRAL SEROTONERGIC CHANGES FOLLOWING ANTIDEPRESSANT TREATMENT - A NEUROENDOCRINE ASSESSMENT
    LEATHERMAN, ME
    EKSTROM, RD
    CORRIGAN, M
    CARSON, SW
    MASON, G
    GOLDEN, RN
    PSYCHOPHARMACOLOGY BULLETIN, 1993, 29 (02) : 149 - 154
  • [38] CHANGES IN PERIPHERAL GENE EXPRESSION FOLLOWING ANTIDEPRESSANT KETAMINE TREATMENT
    Zavaliangos-Petropulu, Artemis
    Boltz, Toni
    Al-Sharif, Noor
    Taraku, Brandon
    Congdon, Eliza
    Espinoza, Randall
    Narr, Katherine
    Ophoff, Roel
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2023, 75 : S124 - S124
  • [39] Antipsychotic type and correlates of antipsychotic treatment discontinuation in the outpatient treatment of schizophrenia
    Haro, JM
    Novick, D
    Belger, M
    Jones, PB
    EUROPEAN PSYCHIATRY, 2006, 21 (01) : 41 - 47
  • [40] Is the Brugada electrocardiogram associated with antipsychotic and antidepressant treatment?
    Kounas, S
    Rouvali, O
    Dalli, P
    Efremidis, M
    Theodoropoulou, S
    Kardaras, F
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S443 - S443
12345